Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

At the June 2024 meeting, the ACIP voted to revise RSV vaccination guidelines. The RSV vaccine was previously recommended for all patients aged 75 and older, with eligibility extended to those ...

Since the ACIP issued the first RSV vaccine recommendation for adults in 2023, the shared decision-making recommendation has proven problematic in clinical practice, Camille Kotton, MD, chair of ...

With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...

Britton A, Roper LE, Kotton CN, et al. Use of respiratory syncytial virus vaccines in adults aged ≥60 years: updated recommendations of the Advisory Committee on Immunization Practices ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

This is a shift from June 21, 2023, when ACIP recommended that adults aged 60 years and older may receive a single dose of the RSV vaccine. 2 These updated recommendations aim to maximize RSV ...

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...

The chair of the CDC’s newly remade vaccine advisory committee said Wednesday that the committee will be reviewing existing ...

All infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, ... “The ACIP’s unanimous recommendations for routine use ...

ACIP's decision was influenced by the outcomes from a Phase III trial that assessed the safety and immune response of the RSV vaccine in the 50 to 59 age group, particularly in those with high ...